期刊文献+

轻度认知损害病人脑脊液白细胞介素-1和肿瘤坏死因子水平的研究 被引量:4

Detection of Interleulin-1β and Tumor Necrosis Factor a in Cerebrospinal Fluid in patients with Mild Cognitive Impairment
下载PDF
导出
摘要 目的:为探讨炎性细胞因子在轻度认知损害(mild cognitive impairment,MCI)慢性炎性病理过程中的作用。方法:本研究采用双抗体夹心酶联免疫吸附实验(enzyme linked immunosorbent assay,ELISA)分别对AD对32例MCI病人与15例正常对照的脑脊液(cerebrospinal fluid,CSF)的自细胞介素IL-1β(Interleukin-1β,IL-1β)和肿瘤坏死因子α(tumor necrosis factors alpha,TNFα)的水平进行了测定。结果:MCI组与正常对照相比,MCI组病人CSF中IL-1β水平和TNFα水平明显升高。结论:上述结果表明,炎性细胞因子IL-1β和TNFα在MCI的神经变性过程起着重要的作用,炎症参与MCI向AD转化发病机制。观察MCI患者CSF的IL-1β水平和TNFα水平可以为早期诊断和治疗提供依据。 Objective: To analyse the cerebrospinal fluid values of the interleulin-1β and tumor necrosis factor a in patients with mild cognitive impairment. Method: The levels of the interleulin-1β and tumor necrosis factor a were analyzed using ELISA in 32patients with MCI and in 15 age matched healthy controls. Result: Patients with MCI displayed significantly higher levels of interleulin-1β and tumor necrosis factor a compared with the healthy controls. Conclusion: These results suggest that premflammatory cytokines interieulin-1β and tumor necrosis factor a should be important factors in the neurodegeneration progress and the inflammation should significantly contribute to trandform MCI into AD. The detection of the level of the interleulin-1β and tumor necrosis factor a in CSF should be valuable to MCI early diagnosis and treatments.
出处 《脑与神经疾病杂志》 2004年第6期429-431,共3页 Journal of Brain and Nervous Diseases
关键词 轻度认知损害 阿尔茨海默病 白细胞介素—1 肿瘤坏死因子 Mild cognitive impairment Alzheimer disease Interleukin-1 Tumor necrosis factor
  • 相关文献

参考文献12

  • 1Stalder AK, Carson MJ, Pagenstecher A, at el. Late-onset chronic inflammatory encephalopathy in immune competent and severe combined-immune deficient(SCID)mice with astrocyte targeted expression of tumor necrosis factor[J]. Am J Pathol,1998,153(3):767~83
  • 2Yue Li, Ling Liu, Steven W, et al. Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38MAPK Pathway[J]. J Neurosci 2003, 23(5): 1605~1611
  • 3Mackenzie IR. Anti-inflammatory drugs and Alzheimer's type pathology in aging[J]. Neurology, 2000, 54(3): 732-4
  • 4Johnson KA, Jones K, Holman BL. Preclinical Prediction of Alzheimer's disease using SPECT. Neurology 1998, 50:1563-1572
  • 5McKelvey R, Bergman H, Stern J. Lack of Prognostic significance of SPECT abnormalities in elderly subjects with a mild memory loss. Can J Neurol Sci 1999,26:23-28
  • 6Krasuki JS, Alexander GE, Horwitz B, et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998, 43:60-68
  • 7McGeer PL, Schulzer M, McGeer GE. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology, 1996,47(2):425-432
  • 8McGeer EG, McGeer PL. Inflammatory Process in Alzheimer's disease. Prog Neuropsychopharmacol Bio Psychiatry. 2003; 27(5)741-749
  • 9Dickson DW, Lee SC, Mattiace LA, et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 1993;7:75-83
  • 10Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by βamyloid protein and interferonγ. Nature, 1995,374:647-650

二级参考文献15

  • 1Griffin WS, Sheng JG, Royston MC, et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle"in disease progression. Brain Pathol, 1998, 8: 65-72.
  • 2McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer's disease. Exp Gerontol, 1998, 33: 371-378.
  • 3American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. Washington: American Psychiatric Association, 1994.92-94.
  • 4McGeer PL, Rogers J, McGeer EG. Neuroimmmune mechanisms in Alzheimer's disease pathogenesis. Alz Dis Assoc Dis, 1994,8:149-158.
  • 5Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci, 2000, 23: 618-625.
  • 6Sheng JG, Griffin WS, Royston MC, et al. Distribution of interleukin-1 immunoreactive microglia in cerebral cortical layers: implication for neuritic plaque formation in Alzheimer's disease. Neuropathol Appl Neurobiol, 1998, 24: 278-283.
  • 7Griffin WS, Sheng JG, Roberts GW, et al. IL-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol, 1995, 54: 276-281.
  • 8Alvarez XA, Franco A, Fernandez N, et al. Blood levels of histamine, IL-1 β and TNF-α in patients with mild to moderate Alzheimer's disease. Mol Chem Neuropathol, 1996, 29: 237-252.
  • 9Licastro F, Pedrini S, Ludovica C, et al. Increased plasma levels of interleukin-1, interleukin-6 and α1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol, 2000, 103: 97-102.
  • 10Dickson DW, Lee SC, Mattiace LA, et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 1993, 7: 75-83.

共引文献19

同被引文献34

  • 1何铭均,陈盛强,林云潮,古文辉.230例广东汉族人肿瘤坏死因子A-308基因多态性的检测[J].广东微量元素科学,2006,13(3):21-25. 被引量:2
  • 2杨炼红,蒋龙元,刘中霖,刘军,陶恩祥,彭英.阿尔茨海默病中肿瘤坏死因子-α基因多态性及表达[J].中华神经医学杂志,2006,5(7):696-698. 被引量:6
  • 3McGeer EG,McGeer PL.Inflammatory process in Alzheimer's disease[J].Prog Neuropsychopharmacol Bio Psychiatry,2003,27(5):741-749.
  • 4Kuo YM,Emmerling MR,Lampert HC,et al.High levels of circulating Aβ1-42 are sequestered by plasma proteins in Alzheimer's disease[J].Biochem Biophys Res Commun,1999,257:787-791.
  • 5Giri RK,Selvaraj SK,Kalra VK.Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA[J].J Immunol,2003,170 (10):5281 -5294.
  • 6Mackenzie IR.Anti-inflammatory drugs and Alzheimer's type pathology in aging[J].Neurology,2000,54(3):732-734.
  • 7Stalder AK,Carson MJ,Pagenstecher A,et al.Late-onset chronic inflammatory encephalopathy in immune competent and severe combined-immune deficient (SCID) mice with astrocyte targeted expression of tumor necrosis factor[J].Am J Pathol,1998,153(3):767-783.
  • 8Stalder AK,Carson MJ,Pagenstecher A,et al.Late-onset chronic inflammatory encephalopathy in immune competent and severe combined-immune deficient (SCID) mice with astrocyte targeted expression of tumor necrosis factor[J].Am J Pathol,1998,153(3):767-783.
  • 9Lee YB,Nagai A,Kim SU.Cytokines,chemokines,and cytokine receptors in human microglia[J].J Neurosci Res,2002,69:94-103.
  • 10Yu SC,Li XY.Effect of ginsenoside on IL-1 beta and IL-6 mRNA expression in hippocampal neurons in chronic inflammation model of aged rats[J].Acta Pharmacol Sin,2000,21 (10):915-918.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部